Laxaco Herbal Laxative
Natural health product licensed in Canada
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 02181444
- Status
- Active licence
- Licence date
- 28 November 2007
- Revision date
- 3 October 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Frangula purshiana Source : Écorce âgée Extraction ratio : 4:1 Dry plant equivalent : 150 mg | 37.5 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, phosphate de dicalcium, silice, Gélatine, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | minimum: 2 weeks ; maximum: 3 weeks |
Uses authorised in Canada
Cascara sagrada has been traditionally used in Herbal Medicine as a stimulant laxative. Cascara sagrada has been used in Herbal Medicine for the short-term relief of occasional constipation. Cascara sagrada has been used in Herbal Medicine to promote bowel movement by direct action on the large intestine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02181444
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging